Key points are not available for this paper at this time.
Classical late-infantile neuronal ceroid lipofuscinosis (LINCL) is a fatal neurodegenerative disease whose defective gene has remained elusive. A molecular basis for LINCL was determined with an approach applicable to other lysosomal storage diseases. When the mannose 6-phosphate modification of newly synthesized lysosomal enzymes was used as an affinity marker, a single protein was identified that is absent in LINCL. Sequence comparisons suggest that this protein is a pepstatin-insensitive lysosomal peptidase, and a corresponding enzymatic activity was deficient in LINCL autopsy specimens. Mutations in the gene encoding this protein were identified in LINCL patients but not in normal controls.
Building similarity graph...
Analyzing shared references across papers
Loading...
David E. Sleat
Robert Donnelly
Henry Lackland
Science
Rutgers, The State University of New Jersey
Johnson University
New York State Office for People With Developmental Disabilities
Building similarity graph...
Analyzing shared references across papers
Loading...
Sleat et al. (Fri,) studied this question.
www.synapsesocial.com/papers/6a0b9cf9e08198424b95d0d2 — DOI: https://doi.org/10.1126/science.277.5333.1802
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: